Volume 14, Issue 1 (1-2016)                   IJRM 2016, 14(1): 23-28 | Back to browse issues page


XML Persian Abstract Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Saki G, Mirhoseini M, Hemadi M, Khodadadi A, Beygom Talebpour Amiri F. The effect of the melatonin on cryopreserved mouse testicular cells. IJRM 2016; 14 (1) :23-28
URL: http://ijrm.ir/article-1-689-en.html
1- Cellular and Molecular research Center, School of Medicine. Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
2- Faculty of Nursing and Midwifery, Mazandaran University of Medical Sciences, Sari, Iran , m.mirhoseini@mazums.ac.ir
3- Infertility and Perinatology Research Center, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
4- Petroleum and Environmental Research Center, School of Medicine, Ahvaz Jundishapur University of Medical Sciences, Ahvaz, Iran
5- Department of Anatomy, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran
Full-Text [PDF 584 kb]   (717 Downloads)     |   Abstract (HTML)  (3104 Views)
Full-Text:   (431 Views)
Introduction
 
There have been extensive advances in the treatment of childhood cancer. As a result, life expectancy has been raised, up to 80% of children survive their diseases; and the population of long-term adult survivors of childhood malignancies is growing (1-3). Unfortunately, these treatments may be toxic to the gonads (4). Semen cryopreservation is a well-developed technique, which is routinely used in many infertility laboratories (5). Cryopreservation is currently (and probably) the best method for long term preservation of spermatogonial stem cells (6).
However, for prepubertal boys who have to undergo chemotherapy or radiotherapy for cancer and cannot produce an ejaculation containing spermatozoa, so an optimized method of testicular tissue cryopreservation is needed (5). There are three different ways for cryobanking of immature testicular tissue containing testicular cell suspension, testicular pieces and entire gonad (7). Testicular stem cell cryopreservation appears the only way to preserve fertility in pre-pubertal testicular cancer patients. Efficacious testicular stem cell transplantation, fresh or frozen-thawed suspension forms has been reported in the recent years (8). A method is developed specifically for cryopreservation of type a spermatogonia, including spermatogonial stem cells, allowing for long-term preservation of these cells without apparent harmful effects on their function (6).
Cryopreservation can reduce the level of spermatozoa antioxidants because of increasing the susceptibility of these cells to peroxidative damages after cryopreservation (9). In both in vivo and in vitro experiments, the melatonin was found to protect tissues against oxidative damages induced by numerous free radicals (10, 11).
The neurohormone melatonin is the major secretory product of the pineal gland. Some physiologic functions of melatonin are: circadian rhythm functions, sleeping and waking up, sexual activity, and reproductive functions, tumor growth, immune response, and aging (12).
It can also act as a strong free radical scavenger and antioxidant (11). Beneficial effects of melatonin in protecting spermatozoa from different kinds of injuries have been reported in the literature. Some researchers showed the anti-apoptotic effects of melatonin on tissues (13, 14). Melatonin can apparently reduce the histological apoptosis, while inducing proliferation of the cells (15). Melatonin could improve cumulus-oocyte complexes quality in vitrified thawed media of murine ovaries (16). However, in another study melatonin did not reduce the injury induced by vitrified thawed media in immature testicular tissues (17).
To our knowledge, there was no any report in the literature regarding the condition of the cryopreserved testicular cells exposed to the freezing media containing melatonin. Therefore, this study determines whether the melatonin ameliorate the apoptosis rate of testicular cells after cryopreservation.
 
Materials and methods
 
Animals
In this experimental study, inbred NMRI mice (7-10 days old males) were obtained from Physiology Research Center, Ahvaz Jundishapur University of Medical Sciences, experimental animal Research Center. Mice were euthanized by with ether and then testes were removed. Finally, animals were sacrificed after cervical dislocation. This study was approved by the Ethics Committee of Ahvaz University and carried out in an ethically way by following the provided guidelines (code; Ajums.rec.1392.125 date; 2013.10.5).
 
Cell isolation Procedure
After removal of tunica albuginea, testes tissues were digested by two-step enzymatic procedure in Milazzo et al way by some modifications (18). Briefly, testicular cells were digested by incubation in 1 mg/ml collagenase type IV (Sigma, St. Louis, MO, USA) and 4 mg/ml DNase (Sigma, St. Louis, MO, USA) in 37ºC incubator for 15 min while being pipetted several times.
Then, in the second step, after centrifuging of the suspension (300 g for 5 minutes), the supernatant was discarded and the cells were re-suspended in the media containing 0.25% trypsin/1 µm Ethylene Diamine Tetraacetic Acid (EDTA) (Invitrogen, Carlsbad, CA) and 0.06 mg/ml DNase I (Sigma, St. Louis, MO, USA) for 5 min in 37ºC incubator. The enzymatic reaction was stopped by adding 10% fetal bovine serum (FBS). Then, the cells were filtered through 70 µm screens for producing a single cell suspension. Approximately, 4×105 cells were collected from a neonatal testis by this procedure.
 
Cryopreservation
For freezing the cells, cryopreservation medium containing 10% (V/V) dimethyl sulfoxide (DMSO) (Sigma, St. Louis, MO, USA), 10% FBS (Gibco, USA), 30 mg/ml penicillin, 50 mg/ml streptomycin (Gibco, USA) was used. The freezing solution was diluted with Dulbecco's Modified Eagle's Medium (DMEM) (Sigma, St. Louis, MO, USA). In brief, after cell count and viability assessment, testicular cell suspensions were aliquoted in 0.5 ml volume (2×106 cells per ml) in two separate cryotubes of 1.8 ml (Jet Biofil, CO, Ltd, China).
Then, an equal volume of 2×concentrated freezing medium was added to the tube during 10-15 min. Cell suspensions were divided into two groups and 100µM melatonin (Sigma-Aldrich, USA) were added in one group. Dose selection was based on previous work (16). The viability of the cells was assessed again and after gently mixing by inverting the vials, samples was preserved in -70ºC overnight. Then they were placed directly into the liquid nitrogen tank at -196oC for long term (20).
 
Thawing procedure
Cryoviales were held in a water bath (38ºC) until defreeze, and then transferred into a tube and diluted slowly by adding two volumes, dropwise, of DMEM containing 10% FBS (19).
 
Cytotoxicity assessment
The lactate dehydrogenase (LDH) released from damaged plasma membranes into the extracellular fluid was determined using the commercially available Cytotoxicity Detection Kit (LDH) (Roche Diagnostics, Mannheim, Germany). The test was performed according to the manufacturer instructions and assessed 
by ELISA reader at 492 nm. High control determined the maximum releasable LDH activity in the cells. High control medium was supplied by addig the lysis buffer (Roche Diagnostics, Mannheim, Germany) in the medium. Each test was repeated in triplicate and measured by ELISA reader.
 
Detection of DNA fragmentation
Apoptotic cells incidence was quantified by flow cytometry using mouse monoclonal antibody, which detected the DNA fragmentation of apoptotic cells. As the DNA breaks, a large number of 3´ hydroxyl ends expose. For detection of apoptotic cells, the APO-Brdu TUNEL Assay Kit (Invitrogen, Carlsbad, CA) was used. The procedure was performed according to the kit instruction. Briefly, approximately 1×106 cells were washed in phosphate-buffered saline (PBS) (Gibco, USA), fixed 15 minutes in 1% paraformaldehyde (Sigma-Aldrich, saint-Quentin fallavier, France) and 5 minutes in ethanol 70% on ice. Then, the cells were incubated in DNA labeling solution in a water bath at 37oC while being shaken for 15 minutes.
Antibody staining solution (100 μL) containing 5μL of the Fluorescein Isothiocyanate (FITC) dye-labeled anti-BrdU mouse monoclonal antibody with 95 μL of rinse buffer were added to each sample and then they were incubated at the room temperature in the darkness. Moreover, the propidium iodide/RNase a staining buffer (0.5 mL) was added to samples and they were incubated at room temperature in the darkness again. At this stage, cell suspension was analyzed by a flow cytometer (Partec Flow Max, Germany).
The positive and negative control cells were provided in the APO-BrdU™ TUNEL Assay Kit. A minimum of 10,000 cells were examined for each test. The fluorochrome was excited with 488 lasers. Green and red fluorescence were detected in the FL1 and FL3 channels of the flow cytometer, respectively. FL1 and FL2 fluorescence signals were recorded with logarithmic amplification and FL3 fluorescence signals were recorded with linear amplification. Apoptotic cells percentage were determined by dot plot of FL1 to FL3. All tests were run in duplicate.
 
Statistical analysis
All data were expressed as a mean±SD. Independent variables were compared using the independent-samples Student’s t-test and Statistical Package for the Social Sciences, version 16.0, SPSS Inc, Chicago, Illinois, USA (SPSS software). Results were considered statistically significant at p≤0.05.
 
Results
 
LDH test
The cytotoxic effect of melatonin was evaluated via LDH. A summary of the mean levels of LDH is shown in table I. The basal level of LDH-release in the high control media was 1.16±0.63. The mean level of LDH leakage was increased in the melatonin supplemented media compared to the melatonin-free media (1.035±.079 vs. 0.755±0.183, respectively), but this increase was not significant (p≤0.05). The amount of melatonin cytotoxicity is 68% based on the kit manufactory formulation.
 
Flow cytometry
Histogram results of FL1 channel are illustrated in figure 1 and dot plot results are shown in figure 2. First, the flow cytometer was set by positive and negative controls. The level of apoptotic cells percentage in the media supplemented with melatonin was significantly increased in comparison to the melatonin-free media (0.23±0.03 vs 0.7±0.14, respectively) (p=0.006). However, there were no significant differences in viability and necrosis rates between these two groups (p≤0.05).

Table I. Toxicity assay data

Cytotoxicity test indicated that melatonin elevates LDH in cryopreserved testicular cells. This increase was not significant (p≤ 0.05).



Figure 1. Flow cytometry study of neonate mouse testicular cells. Single parameter histograms are in FL1. The graphs display a single measurement parameter (relative fluorescence or light scatter intensity) on the x-axis and the number of event (cell count) on the y-axis. Melatonin increased the apoptotic cells which was kept in the cryopreserved media compared to the melatonin-free media (0.7±0.14 vs 0.23 ±0.03, respectively) (p=0.006). (A) Positive control. (B) Negative control. (C) Melatonin free group. (D) Melatonin group.



Figure 2. Dual-color dot plot of Brdu-FITC / Propidium Idide (PI) flow cytometry study. Cells were analyzed for Brdu-FITC in forward scatter and red fluorescence (PI) in side scatter. Lower left of each quadrant indicates cells not to stain (viability percentage) and lower right stained positive for Brdu- FITC showing apoptosis percent and upper right stained positive for Brdu- FITC and PI indicates the percent of late apoptosis and necrosis and upper left that stained with PI shows necrotic cells. The control groups were supplied with the kit. As it was showed, melatonin could significantly increase the apoptotic cells in the cryopreserved media (0.7±0.14 vs. 0.23±0.03, respectively) (p=0.006). (A) Negative control. (B) Positive control. (C) Melatonin group. (D) Melatonin free group.


Discussion
 
In the present study, the effect of supplementation of the cryopreservation medium with melatonin on frozen testicular cells of the mouse was assessed. Melatonin which is the chief secretary product of the pineal gland has a very strong antioxidant activity, depending mainly on its capacity to act as an electron donor (11). Melatonin acts directly as a free radical scavenger, whereas the indirect actions of melatonin occur when it stimulates the endogenous antioxidant enzymes (20, 21). In vivo and in vitro, melatonin  has  been  found  to protect tissues
 
 
against oxidative damages generated by a variety of toxic agents and metabolic processes, including oxidative damage in testis (22), chemotherapy-induced toxicity (23) and ischemia-reperfusion injuries in stomach, liver, and brain (24). However, in this study melatonin could not only prevent toxic effects of freezing on testicular cells, it also had toxic effects. Indeed, melatonin cannot prevent the release of LDH. LDH is a stable cytoplasmic enzyme presented in all cells. It is rapidly released into the cell culture supernatant upon damage of the plasma membrane (25, 26).
Also, in the current study, it is shown that supplementation of the cryopreserved medium with melatonin causes increased apoptotic cell death in testicular cells. Hemadi et al suggested that the use of melatonin right after thawing vitrified testis tissue and subsequent melatonin treatment during transplantation is a feasible approach to better maintain the potential of spermatogenesis kinetics, and it may serve as a promising method for graft preservation (16). These results are in contradiction with the current results. The differences may be due to the addition of melatonin to thawing solution by Hemadi et al whereas we added the melatonin to the cryopreservation media. Moreover, they freezed the whole testis, while we preserved testicular cells (15). Previously, a comparative study was performed in which cryopreservation of testicular tissue was carried out with vitrification medium supplemented with melatonin versus the melatonin-free medium. The increase in apoptosis was observed in the media supplemented with melatonin (17). These results are in agreement with our experiments. Mohamad-Ghasemi et al stated that melatonin has a protective effect on epididymal sperm parameters, seminal vesicle and epididymis morphology in mouse under treatment with chemotherapy (27).
They declared that although the mechanism is not clear, it acts probably by decreasing oxidative stresses. In another study, it was achieved the protective effect of melatonin in busulfan treated mice (28). Apparently, melatonin treatment produces antioxidant effect in vivo. Succu et al claimed that adding melatonin to the ram semen vitrification solution protects the spermatozoa during cryopreservation in a dose-dependent manner. So, the difference in the melatonin dosage may cause to such different results (29). In another study, it was found that melatonin has an anti-apoptotic effects on germ cells (unpublished data). In that study, we purified the CD 90.1+germ cells by magnetic activated cell sorting (MACS). It appears that melatonin has an anti-oxidant effect on purified spermatogonial stem cell, but it has a contentious effect on gross population of testicular cells, so the results may be different if it is repeated by a pure population of spermatogonial stem cells. It can largely be provided by MACS method. The difference between actual absorption rate of melatonin with antioxidant effect and toxic effect may be another reason for these different results (29). Evaluation of data from prolonged multicentral studies seems to be essential for determination of the safe and effective dose of melatonin along with achieving maximum benefit and minimum adverse events of it (30).
 
Conclusion
 
In conclusion, our results indicated that melatonin has apoptotic effect on testicular cells in cryopreservation media.
 
Acknowledgments
 
This was a part of the Ph.D. thesis of Mehri Mirhoseini, which has approved by the Physiology Research Center. We are grateful to Ahvaz Jundishapur University of Medical Sci­ences for the financial support.
 
Conflict of interest
 
All authors declare that there are no conflicts of interest.
 

 
Type of Study: Original Article |

References
1. Magnani C, Pastore G, Coebergh JW, Viscomi S, Spix C, Steliarova-Foucher E. Trends in survival after childhood cancer in Europe 1978–1997: report from the Automated Childhood Cancer Information System project (AGCIS). Eur J Cancer 2006; 42: 1981-2005. [DOI:10.1016/j.ejca.2006.05.006]
2. Steliarova-Foucher E, Stiller C, Kaatsch P, Berrino F, Coebergh JW, Lacour B, et al. Geographical patterns and time trends of cancer incidence and survival among children and adolescents in Europe since the 1970s (The ACCIS project): an epidemiological study. Lancet 2004; 364: 2097-2105. [DOI:10.1016/S0140-6736(04)17550-8]
3. Brenner H, Steliarova-Foucher E, Arndt V. Up-to-date monitoring of childhood cancer long-term survival in Europe methodology and application to all forms of cancer combined. Ann Oncol 2007; 18: 1561-1568. [DOI:10.1093/annonc/mdm186]
4. Bleyer A. The impact of childhood cancer on the United States and the world. CA Cancer J Clin 1990; 40: 355-367. [DOI:10.3322/canjclin.40.6.355]
5. Keros V, Hultenby K, Borgstrom B, Fridstrom M, Jahnukainen K, Hovatta O. Methods of cryopreservation of testicular tissue with viable spermatogonia in pre-pubertal boys undergoing gonadotoxic cancer treatment. Hum Reprod 2007; 22: 1384-1395. [DOI:10.1093/humrep/del508]
6. Milazzo JP, Vaudreuil L, Cauliez B, Gruel E, Masse´ L, Mousset-Sime´on N, et al. Comparison of conditions for cryopreservation of testicular tissue from immature mice. Hum Reprod 2008; 23: 17-28. [DOI:10.1093/humrep/dem355]
7. Tournaye H, Goossens E, Verheyen G, Frederickx V, De Block G, Devroey P, et al. Preserving the reproductive potential of men and boys with cancer: current concepts and future prospects. Hum Reprod Update 2004; 10: 525-532. [DOI:10.1093/humupd/dmh038]
8. Succu S, Berlinguer F, Pasciu V, Satta V, Leoni GG, Naitana S. Melatonin protects ram spermatozoa from cryopreservation injuries in a dose-dependent manner. J Pineal Res 2011; 50: 310-318. [DOI:10.1111/j.1600-079X.2010.00843.x]
9. Sener G, Atasoy BM, Ersoy Y, Arbak S, Sengoz M, Yegen BC. Melatonin protects against ionizing radiation-induced oxidative damage in corpus cavernosum and urinary bladder in rats. J Pineal Res 2004; 37: 241-246. [DOI:10.1111/j.1600-079X.2004.00161.x]
10. Reiter RJ, Melchiorri D, Sewerynek E, Poeggeler B, Barlow-Walden L, Chuang J, et al. A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18: 1-11. [DOI:10.1111/j.1600-079X.1995.tb00133.x]
11. Sanchez-Hidalgo M, de la Lastra CA, Carrascosa-Salmoral MP, Naranjo MC, Gomez-Corvera A, Caballero B, et al. Age-related changes in melatonin synthesis in rat extrapineal tissues. Exp Gerontol 2009; 44: 328-334. [DOI:10.1016/j.exger.2009.02.002]
12. Guneli E, Tugyan K, Ozturk H, Gumustekin M, Cilaker S, Uysal N. Effect of melatonin on testicular damage in streptozotocin-induced diabetes rats. EurSurg Res 2008; 40: 354-360. [DOI:10.1159/000118032]
13. Bejarano I, Redondo PC, Espino J, Rosado JA, Paredes SD, Barriga C, et al. Melatonin induces mitochondrial-mediated apoptosis in human myeloid HL-60 cells. J Pineal Res 2009; 46: 392-400. [DOI:10.1111/j.1600-079X.2009.00675.x]
14. Hemadi M, Abolhassani F, Akbari M, Sobhani A, Pasbakhsh P, Ahrlund-Richter L, et al. Melatonin promotes the cumulus-oocyte complexes quality of vitrified-thawed murine ovaries; with increased mean number of follicles survival and ovary size following heterotopic transplantation. Eur J Pharmacol 2009; 618: 84-90. [DOI:10.1016/j.ejphar.2009.07.018]
15. Gholami MR, Saki G, Hemadi M, Khodadadi A, Mohammadi-Asl J. Supplementation vitrified-thawed media with melatonin do not protecting immature mouse testicular tissue from vitrified-thawed induced injury. Asian J Anim Vet Adv 2012; 7: 940-949. [DOI:10.3923/ajava.2012.940.949]
16. Milazzo JP, Vaudreuil L, Cauliez B, Gruel E, Masse L, Mousset-Simeon N, et al. Comparison of conditions for cryopreservation of testicular tissue from immature mice. Hum Reprod 2008; 23: 17-28. [DOI:10.1093/humrep/dem355]
17. Oatley JM, Reeves JJ, McLean DJ. Biological activity of cryopreserved bovine spermatogonial stem cells during in vitro culture. Biol Reprod 2004; 71: 942-947. [DOI:10.1095/biolreprod.104.028894]
18. Shirazi A, Ghobadi G, Ghazi-Khansari M. A radiobiological review on melatonin: a novel radioprotector. J Radiat Res 2007; 48: 263-272. [DOI:10.1269/jrr.06070]
19. Karbownik M, Reiter RJ. Antioxidative effects of melatonin in protection against cellular damage caused by ionizing radiation. Proc Soc Exp Biol Med 2000; 225: 9-22. [DOI:10.1046/j.1525-1373.2000.22502.x]
20. Nasiraei-Moghadam SN, Parivar K, Ahmadiani A, Movahhedin M, Vaez Mahdavi MR. Protective effect of melatonin against inequality-induced damages on testicular tissue and sperm parameters. Int J Fertil Steril 2014; 7: 313-322.
21. Lissoni P, Tancini G, Barni S, Paolorossi F, Ardizzoia A, Conti A, et al. Treatment of cancer chemotherapy-induced toxicity with the pineal hormone melatonin. Support Care Cancer 1997; 5: 126-129. [DOI:10.1007/BF01262569]
22. Sewerynek E, Reiter RJ, Melchiorri D, Ortiz GG, Lewinski A. Oxidative damage in the liver induced by ischemia-reperfusion: protection by melatonin. Hepatogastroenterology 1996; 43: 898-905.
23. Korzeniewski C, Callewaert DM. An enzyme-release assay for natural cytotoxicity. J Immunol Methods 1983; 64: 313-320. [DOI:10.1016/0022-1759(83)90438-6]
24. Weyermann J, Lochmann D, Zimmer A. A practical note on the use of cytotoxicity assays. Int J Pharm 2005; 288: 369-376. [DOI:10.1016/j.ijpharm.2004.09.018]
25. Mohamad-Ghasemi F, Faghani M, Khajehjahromi S, Bahadori M, Nasiri E, Hemadi M. Effect of melatonin on proliferative activity and apoptosis in spermatogenic cells in mouse under chemotherapy. J Reprod Contracep 2010; 21: 79-94. [DOI:10.1016/S1001-7844(10)60016-8]
26. Mirhoseini M, Saki G, Hemadi M, Khodadadi A, Mohammadi- Asl J. Melatonin and testicular damage in busulfan treated Mice. Iran Red Crescent Med J 2014; 16: e14463. [DOI:10.5812/ircmj.14463]
27. Succu S, Berlinguer F, Pasciu V, Satta V, Leoni GG, Naitana S. Melatonin protects ram spermatozoa from cryopreservation injuries in a dose-dependent manner. J Pineal Res 2011; 50: 310-318. [DOI:10.1111/j.1600-079X.2010.00843.x]
28. Yoshikazu Y, Atsuhiko H, Kazuyoshi T, Masako O, Bunpei I. Effects of Melatonin: Basics Studies and Clinical Applications. Anti-aging Medicin 2010; 7: 85-91.

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

Designed & Developed by : Yektaweb